• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞生长因子表达增加诱导胃癌对c-MET酪氨酸激酶抑制剂产生耐药性。

Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer.

作者信息

Ahn So Yeong, Kim Jin, Kim Min A, Choi Jiwoon, Kim Woo Ho

机构信息

Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Republic of Korea.

Department of Pathology, Seoul National University Hospital, Seoul, Republic of Korea.

出版信息

Anticancer Res. 2017 Mar;37(3):1127-1138. doi: 10.21873/anticanres.11426.

DOI:10.21873/anticanres.11426
PMID:28314274
Abstract

BACKGROUND

Increased expression of hepatocyte growth factor (HGF) and MET proto-oncogene (c-MET) is associated with poor prognosis in various cancer types. Recently, it was reported that the expression of HGF induces resistance to tyrosine kinase inhibitors (TKIs) targeting epidermal growth factor receptor, human epidermal receptor receptor 2, and b-raf proto-oncogene. Here, we investigated the effects of HGF overexpression in gastric cancer cells in the absence or presence of c-MET TKIs.

MATERIALS AND METHODS

The effects of c-MET TKIs in gastric cancer cells with and without c-MET overexpression were determined in gastric cancer cell lines with various cell biology methods.

RESULTS

Compared to the control, cells with induced expression of HGF showed increase in anchorage-independent colony formation (p<0.001). The c-MET TKIs inhibited HGF/c-MET downstream signaling, cell proliferation, migration and invasion, and triggered cell-cycle arrest in Hs746T cells. However, HGF-transfected cells were less affected.

CONCLUSION

c-MET TKIs had inhibitory effects only on cells overexpressing c-MET. Furthermore, overexpression of HGF resulted in resistance to c-MET TKIs through an autocrine manner in gastric cancer cells.

摘要

背景

肝细胞生长因子(HGF)和MET原癌基因(c-MET)表达增加与多种癌症类型的不良预后相关。最近,有报道称HGF的表达会诱导对靶向表皮生长因子受体、人表皮受体2和b-raf原癌基因的酪氨酸激酶抑制剂(TKIs)产生耐药性。在此,我们研究了在有无c-MET TKIs的情况下,HGF过表达对胃癌细胞的影响。

材料与方法

采用多种细胞生物学方法,测定c-MET TKIs对有无c-MET过表达的胃癌细胞的影响。

结果

与对照组相比,诱导表达HGF的细胞在非锚定依赖性集落形成方面有所增加(p<0.001)。c-MET TKIs抑制Hs746T细胞中HGF/c-MET下游信号传导、细胞增殖、迁移和侵袭,并引发细胞周期停滞。然而,转染HGF的细胞受影响较小。

结论

c-MET TKIs仅对过表达c-MET的细胞有抑制作用。此外,HGF的过表达通过自分泌方式导致胃癌细胞对c-MET TKIs产生耐药性。

相似文献

1
Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer.肝细胞生长因子表达增加诱导胃癌对c-MET酪氨酸激酶抑制剂产生耐药性。
Anticancer Res. 2017 Mar;37(3):1127-1138. doi: 10.21873/anticanres.11426.
2
Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.肝细胞生长因子和 c-Met 的共表达通过自分泌肝细胞生长因子/c-Met 信号预测胃癌腹膜转移的建立。
Int J Cancer. 2012 Jun 15;130(12):2912-21. doi: 10.1002/ijc.26330. Epub 2011 Sep 12.
3
Norcantharidin combined with EGFR-TKIs overcomes HGF-induced resistance to EGFR-TKIs in EGFR mutant lung cancer cells via inhibition of Met/PI3k/Akt pathway.去甲斑蝥素联合表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKIs)通过抑制Met/PI3k/Akt信号通路克服了HGF诱导的EGFR突变肺癌细胞对EGFR-TKIs的耐药性。
Cancer Chemother Pharmacol. 2015 Aug;76(2):307-15. doi: 10.1007/s00280-015-2792-x. Epub 2015 Jun 11.
4
Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.成纤维细胞分泌的肝细胞生长因子通过旁分泌激活Met介导三阴性乳腺癌对表皮生长因子受体酪氨酸激酶抑制剂的耐药性。
Breast Cancer Res. 2012 Jul 12;14(4):R104. doi: 10.1186/bcr3224.
5
Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.双重抑制 Met 激酶和血管生成以克服 HGF 诱导的 EGFR 突变型肺癌中 EGFR-TKI 耐药性。
Am J Pathol. 2012 Sep;181(3):1034-43. doi: 10.1016/j.ajpath.2012.05.023. Epub 2012 Jul 9.
6
Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.甲磺酸酪氨酸激酶抑制剂PF-2341066可抑制鼻咽癌的生长和侵袭。
Drug Des Devel Ther. 2015 Aug 26;9:4897-907. doi: 10.2147/DDDT.S85837. eCollection 2015.
7
MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells.MET 激活介导了对曲妥珠单抗耐药的 HER2 扩增胃癌细胞对拉帕替尼的抑制作用。
Mol Cancer Ther. 2012 Mar;11(3):660-9. doi: 10.1158/1535-7163.MCT-11-0754. Epub 2012 Jan 11.
8
The role of MET activation in determining the sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors.MET 激活在确定表皮生长因子受体酪氨酸激酶抑制剂敏感性中的作用。
Mol Cancer Res. 2009 Oct;7(10):1736-43. doi: 10.1158/1541-7786.MCR-08-0504. Epub 2009 Oct 6.
9
Hepatocyte growth factor/MET in cancer progression and biomarker discovery.肝细胞生长因子/间质上皮转化因子在癌症进展及生物标志物发现中的作用
Cancer Sci. 2017 Mar;108(3):296-307. doi: 10.1111/cas.13156.
10
Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.抗 c-MET 纳米抗体——多发性骨髓瘤治疗的新潜在药物。
Eur J Haematol. 2013 Nov;91(5):399-410. doi: 10.1111/ejh.12185. Epub 2013 Sep 16.

引用本文的文献

1
Fuelling the Fight from the Gut: Short-Chain Fatty Acids and Dexamethasone Synergise to Suppress Gastric Cancer Cells.从肠道助力抗癌:短链脂肪酸与地塞米松协同抑制胃癌细胞
Cancers (Basel). 2025 Jul 28;17(15):2486. doi: 10.3390/cancers17152486.
2
The role and research progress of the MET signalling pathway in targeted therapy for osteosarcoma.MET信号通路在骨肉瘤靶向治疗中的作用及研究进展
Oncol Rev. 2025 Jun 17;19:1615111. doi: 10.3389/or.2025.1615111. eCollection 2025.
3
Phosphorylation of MET Is Upregulated in Metastatic Sites of Renal Cell Carcinoma: Possible Role of MET and Hepatocyte Growth Factor Activation-Targeted Combined Therapy.
MET磷酸化在肾细胞癌转移部位上调:MET和肝细胞生长因子激活靶向联合治疗的潜在作用
Biomedicines. 2025 Mar 28;13(4):811. doi: 10.3390/biomedicines13040811.
4
Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review.肝细胞生长因子/c-Met信号通路在胃癌中发展的研究进展:综述
World J Gastrointest Oncol. 2024 Aug 15;16(8):3397-3409. doi: 10.4251/wjgo.v16.i8.3397.
5
Ferroptosis regulating lipid peroxidation metabolism in the occurrence and development of gastric cancer.铁死亡在胃癌发生发展中调节脂质过氧化代谢。
World J Gastrointest Oncol. 2024 Jun 15;16(6):2781-2792. doi: 10.4251/wjgo.v16.i6.2781.
6
SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer.SMYD3 调控胃癌中的 HGF/MET 信号通路。
Cells. 2023 Oct 18;12(20):2481. doi: 10.3390/cells12202481.
7
Human telomerase reverse transcriptase promotes the epithelial to mesenchymal transition in lung cancer cells by enhancing c-MET upregulation.人端粒酶逆转录酶通过增强c-MET上调促进肺癌细胞的上皮-间质转化。
Heliyon. 2021 Dec 24;8(1):e08673. doi: 10.1016/j.heliyon.2021.e08673. eCollection 2022 Jan.
8
Blockage of ETS homologous factor inhibits the proliferation and invasion of gastric cancer cells through the c-Met pathway.ETS同源因子的阻断通过c-Met途径抑制胃癌细胞的增殖和侵袭。
World J Gastroenterol. 2020 Dec 21;26(47):7497-7512. doi: 10.3748/wjg.v26.i47.7497.
9
Targeting HGF/c-MET Axis in Pancreatic Cancer.靶向治疗胰腺癌中的 HGF/c-MET 轴。
Int J Mol Sci. 2020 Dec 1;21(23):9170. doi: 10.3390/ijms21239170.
10
Mechanisms of Acquired Resistance to Savolitinib, a Selective MET Inhibitor in -Amplified Gastric Cancer.选择性MET抑制剂赛沃替尼在MET扩增型胃癌中获得性耐药的机制
JCO Precis Oncol. 2020 Mar 24;4. doi: 10.1200/PO.19.00386. eCollection 2020.